Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6999-7007
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6999
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6999
Figure 3 Receiver operating characteristic curves of prolidase and alpha fetoprotein levels.
A: Predictive value of prolidase and α-fetoprotein (AFP) regarding tumor size (diameters; ≤ 3 cm and > 3 cm ); B: Predictive value of prolidase and AFP regarding tumor number (number; ≤ 1 and ≥ 2 ).
- Citation: Uygun Ilikhan S, Bilici M, Sahin H, Demir Akca AS, Can M, Oz II, Guven B, Buyukuysal MC, Ustundag Y. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. World J Gastroenterol 2015; 21(22): 6999-7007
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6999.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6999